Genetic polymorphisms in drug metabolizing enzymes, transporters, receptors, and other drug targets have been linked to interindividual differences in the efficacy and toxicity of many medications. Pdf during the last decade, a greater focus has been given to impact of. Here, we studied the association between mdr1 c3435t polymorphism and susceptibility to. The frequency distribution of cyp2c9 polymorphism alleles in patients with epilepsy around the world ranges from 4. Genetic polymorphisms and mutations in drug metabolizing enzymes, transporters, receptors, and other drug targets e. Feb 03, 2014 genetic polymorphism in drug transport 1.
However, genetic factors are also likely to play a major role, since the individual response to. Miller a frica is the area of the world most threatened by malaria because it has the most efficient mosquito vectors, the anopheles gambiae complex. Polymorphisms in the abc drug transporter gene mdr1 the. Recent screening for polymorphisms in other transporters has revealed missense mutations slc6a4, encoding the serotonin trans. Polymorphisms in genes responsible for drug transport can affect. Effects of organic anion transporting polypeptide oatp1b1. Polymorphism of the drugmetabolizing enzyme family ugt1a is a known contributor to varied response and toxicity of irinotecan in different individuals.
Genetic polymorphisms of drugmetabolizing enzymes give rise to distinct subgroups in the population that differ in their ability to perform certain drug biotransformation reactions. Genetic polymorphisms of drug metabolizing enzymes give rise to distinct subgroups in the population that differ in their ability to perform certain drug biotransformation reactions. Polymorphism of multiple drug transport proteins, such as abcb1, abcc1, abcc2, abcg2, and slc01b1 have been suggested to have additive or synergistic effects with ugt1a1. Population differences in drug response, including susceptibility to adverse drug reactions, are affected by genetic polymorphisms. The first drug metabolising polymorphism was described over 40 years ago for acetylation. May 11, 2011 other genetic factors not discussed in this article also affect drug transport proteins, drug absorption, drug receptors, and drug excretion. Pharmacogenomic studies are rapidly elucidating the inherited nature of these differences in drug disposition and effects, thereby enhancing drug discovery and providing a stronger scientific. Cytochrome p450 2a6 cyp2a6 is the principal enzyme involved in the metabolic activation of tobaccospecific nitrosamines to their ultimate carcinogenic forms and metabolism of nicotine.
Impact of malaria on genetic polymorphism and genetic. Other genetic factors not discussed in this article also affect drug transport proteins, drug absorption, drug receptors, and drug excretion. Drugdrug interactions, drugfood interactions, sex, age, disease state ie, renal and hepatic function and pregnancy can all influence variability in drug responses between patients. This metabolises both mercaptopurine and azathioprine and 1 in 300 of caucasians have very low enzyme activity. Multidrug resistance 1 genetic polymorphism and prediction. Genetic variability in drug transport, metabolism or dna. Genetic polymorphisms in drugmetabolizing enzymes, transporters, receptors, and other drug targets have been linked to interindividual differences in the efficacy and toxicity of many medications. It has been suggested that genetic polymorphisms in drug transporters as well as drugmetabolizing enzymes are associated with interindividual differences in drug disposition, efficacy, and toxicity and in. An important factor responsible for this variability is genetic polymorphism in genes that are involved in pkpd processes, including drug transporters, phase i and ii metabolizing enzymes, and drug targets, and other genes that interfere with drug response. Genetic polymorphisms of drug eliminating enzymes and. Effects of organic anion transporting polypeptide oatp1b1slco1b1 genetic polymorphism on statin therapy. Each separate arrangement is a different polymorphic. The clinical role of genetic polymorphisms in drug.
A drug that is quickly metabolized is broken down sooner and a higher dose might be needed to be effective. Pharmacogenetics is an important field emerging in context to diabetes research, primarily due to genetic polymorphisms that have been found in drug metabolizing genes and which affect absorption, metabolism and excretion of almost all antidiabetic drugs. Pharmacogenetic variability in drug transport and phase i. Genetic polymorphism of cyp2c9 may reduce the metabolism of pht by 2550% in patients with variants 2 and 3 compared to those with wildtype variant 1.
There is wide variability in the response of individuals to standard doses of drug therapy. We are just beginning to appreciate their role for drug delivery and disposition and the contribution of genetic polymorphisms in these transport proteins to interindividual variability in the efficacy and safety for pharmacotherapy. Association of multidrug resistance in epilepsy with a. Wide individual variations exist in the expression and function of cyp450 enzymes. Pharmacogenomic studies are rapidly elucidating the inherited nature of these differences in drug disposition and effects, thereby enhancing drug discovery and providing a stronger scientific basis. Polymorphisms in genes coding for metabolising enzymes and drug transporters can affect drug efficacy and toxicity. The polymorphic p450 cyp enzyme superfamily is the most important system involved in the biotransformation of many endogenous and exogenous substances including drugs, toxins, and carcinogens. Genetic polymorphisms for many drugmetabolizing enzymes and drug targets have been identified. Genetic variation frequencies differ among different ethnicities. Association study of genetic polymorphisms in proteins involved in oseltamivir transport, metabolism, and interactions with adverse reactions in mexican patients with acute respiratory diseases. The human multidrug resistance gene mdr1, which encodes the major transmembrane transporter pglycoprotein pgp, was found to be associated with susceptibility to cancer and response to chemotherapy.
Full text genetic polymorphism of the methotrexate. The bioavailability and metabolism of cyclosporine and tacrolimus are primarily controlled by efflux pumps and members of the cytochrome p450 cyp isoenzyme system found in the liver and gastrointestinal tract. Accordingly, organic cations that are transported by octn2 are suggested to exhibit altered pharmacokinetic behavior in the people who have the heterozygousity. The purpose of the present study was to investigate the impact of genetic polymorphism on fluvastatin pharmacokinetics. Pharmacogenetics aims to identify individuals predisposed to a high.
Department of pharmacology and therapeutics, faculty of clinical medicinem, ebonyi state university, abakaliki, nigeria. Polymorphisms refer to sequence variations with an allele frequency of greater than or equal to 1%. Genetic polymorphisms in drug transporters and phase1 drugmetabolizing enzymes can. Implications of genetic polymorphisms in drug transporters. In addition, we compared the fluvastatin pharmacokinetics differences between extendedrelease er 80 mg tablet and immediaterelease ir 40 mg capsule in terms of drug metabolism enzyme and transporter genetic polymorphisms. Here, we studied the association between mdr1 c3435t polymorphism and.
Drugrelated genetic polymorphisms affecting severe chemothe. Introduction transporters are those proteins that carry either endogenous compounds or xenobiotics across biological membranes. Polymorphic drug metabolism genetic polymorphism the metabolic capacity of the cyp enzyme system is not equal in all members of a population. Additionally, genetic variation such as singlenucleotide polymorphisms snps of the transport proteins can cause differences in the uptake or. The human multi drug resistance gene mdr1, which encodes the major transmembrane transporter pglycoprotein pgp, was found to be associated with susceptibility to cancer and response to chemotherapy.
Genetic factors in drug metabolism american family physician. Jun 01, 2008 genetic factors in drug metabolism donna j. Polymorphism of the drug metabolizing enzyme family ugt1a is a known contributor to varied response and toxicity of irinotecan in different individuals. Request pdf genetic polymorphisms of drug transporters. This study aimed to determine whether single nucleotide polymorphisms snps in genes involved in. African populations have disproportionately high incidences of adverse drug reactions, 1 and one of the potential contributing factors may be a higher genetic diversity in africa than in other continental populations. The extent of expression of genes coding for transport. More recently, adverse drug reactions such as nausea, diplopia, and blurred vision after the antiarrhythmic and oxytocic drug sparteine, or incapacitating orthostatic hypotension after the antihypertensive agent debrisoquine have led to the discovery of the genetic polymorphism of the drug metabolising enzyme cytochrome p450 2d6 cyp2d6. Polymorphism in any one of many genes including those encoding drug receptors, drug transporter are important determinants of clinical response. If a cytochrome p450 enzyme metabolizes a drug slowly, the drug stays active longer and less is needed to get the desired effect. Pharmacogenomics of drug metabolizing enzymes and transporters.
Pdf genetic polymorphisms and implications for human diseases. This is an important problem in clinical practice, where it can lead to therapeutic failures or adverse drug reactions. As a result, the metabolic conver sion and excretion rate of drugs vary between individuals, from extremely slow to ultrafast. An example of pharmacokinetic process variation is genetic polymorphisms for many. Cytochrome p450 genetic polymorphism in neonatal drug.
Pharmacogenetics and adverse drug reactions the lancet. Thus, polymorphism can affect the quality, safety, and efficacy of the drug product. We investigated the effects of the cyp2a64, an entire cyp2a6 gene deletiontype polymorphism, on lung cancer risk and daily cigarette consumption in japanese male smokers via a hospitalbased case control. Genetic polymorphism of cyp2a6 gene and tobaccoinduced. Drug therapy gets personal with genetic profiling american.
Drug disposition, drug targets german cancer research center. Depending on the gene and the polymorphism, drugs can be metabolized quickly or slowly. Genetic polymorphisms and implications for human diseases article pdf available in journal of the medical association of thailand chotmaihet thangphaet 902. Pdf pharmacogenetics of drug transporters researchgate. Recently seven different genes encoding drug transporters have been found in the mrp locus 15 but the genetic polymorphism of this locus has to be worked out.
The maturation of organ systems, paralleled by ontogeny of drugmetabolizing enzymes during fetal life and in the first months of postnatal life, surely exerts profound effects on drug disposition, probably being the predominant factor accounting for ageassociated changes in. The aim was to analyze the role of genetic polymorphisms of enzymes involved in methadone metabolism and transport in opioiddependent patients in mmt and the relationship of polymorphisms with treatment outcome, methadone doses, and methadone plasmatic concentrations. It is now clear that a significant proportion of these adverse drug reactions, as well as therapeutic failures, are caused by genetic polymorphism, genetically based interindividual differences in drug absorption, disposition, metabolism. Thus, genetic variants of slco1b1 could contribute to the genetic component of variable mdr1 transport, advising the conclusion that transporters, metabolizing enzymes and regulatory factors should be viewed and evaluated as an integrative system rather than single components when analyzing the genetics of drug response disposition, efficacy, toxicity. More recently, adverse drug reactions such as nausea, diplopia, and blurred vision after the antiarrhythmic and oxytocic drug sparteine, or incapacitating orthostatic hypotension after the antihypertensive agent debrisoquine have led to the discovery of the genetic polymorphism of the drugmetabolising enzyme cytochrome p450 2d6 cyp2d6. There are a number of other genetic polymorphisms of interest in relation to drug metabolism, the most notable of which is thiopurine methyltransferase tpmt. The extent of expression of genes coding for transport proteins. Drug metabolism is conventionally described as consisting of phase 1 oxidation reactions, primarily mediated by cytochrome p450 enzymes in the liver, and phase 2 conjugations such as glucuronidation, sulphation and acetylation. Major determinants in these transport processes are atpdependent efflux pumps such as pglycoprotein and related proteins eg mrps, which. Genetic polymorphism of metabolic enzymes p450 cyp as a susceptibility factor for drug response, toxicity, and cancer risk. The effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors were examined. Direct url citations appear in the printed text and are provided in the html and pdf.
Relationship between genetic polymorphisms of drug efflux. Genetic polymorphisms for many drug metabolizing enzymes and drug targets have been identified. Since all polymorphism has a genetic basis, genetic polymorphism has a particular meaning. Genetic polymorphism is the simultaneous occurrence in the same locality of two or more discontinuous forms in such proportions that the rarest of them cannot be maintained just by recurrent mutation or immigration, originally defined by ford 1940. The cytochrome p450 cyp enzyme system is involved in the. A growing number of preclinical and clinical studies have demonstrated that the application of genetic information may be useful in individualised pharmacotherapy for numerous diseases. This is the first demonstration of genetic polymorphism in organic cation transporters found in normal population. The influence of genetic polymorphisms in drug metabolism. Variants leading to reduced or increased enzymatic activity as compared to the.
Genetic polymorphisms of drug transporters researchgate. As such, the field covers the area of the genetic basis of pharmacokinetics and pharmacodynamics, basic drug development, patient genetic testing, and clinical patient drug trials. We investigated the effects of the cyp2a64, an entire cyp2a6 gene deletiontype polymorphism, on lung cancer risk and daily cigarette consumption in japanese male smokers via a. Polymorphisms in the abc drug transporter gene mdr1 nature. For most drug metabolizing enzymes dmes, the functional consequences of genetic polymorphisms have been examined. Oct 14, 2012 there is wide variability in the response of individuals to standard doses of drug therapy. Chapter 5 pharmacogenomics and drug transportefflux. An important factor responsible for this variability is genetic polymorphism in genes that are involved in pkpd processes, including drug. Genetic polymorphism of organic anion and cation transporters.
Jun 21, 2001 functionality of the atp domains, as well as correct interaction of these with the drug binding domains are necessary for drug transport. Cytochrome p450 and abcb1 genetic polymorphisms and methadone. Genetic polymorphisms of drugmetabolising enzymes and drug. Effects of genetic polymorphisms on the pharmacokinetics of.
Genetic polymorphism and snps genotyping, haplotype assembly problem, haplotype map, functional genomics and proteomics february 19, 2002 prepared by kaleigh smith 1 introduction to snps thefollowingdocumentprovidesanintroductionsinglenucleotidepolymorphismsandthemotivationtheyprovideforcurrentresearchinpharmacogenomicsandotherareasandthetechnology. Aldosari ms 2016 genetic polymorphisms of drug eliminating enzymes and transporters iomed genet genomics 2016 doi. Association study of genetic polymorphisms in proteins. Since octn2 plays a role in carnitine transport by mediating especially a renal reabsorption of carnitine from urine, free carnitine concentrations in blood and urine were used for phenotyping of the genetic mutation of octn2.
Genetic polymorphism of metabolic enzymes p450 cyp as a. Genetic polymorphism of cyp2a6 gene and tobaccoinduced lung. Impact of malaria on genetic polymorphism and genetic diseases in africans and african americans louis h. Genetic polymorphism defined where monomorphism means having only one form and dimorphism means there are only two forms, the term polymorphism is a very specific term in genetics and biology. Genetic polymorphisms, drug metabolism and drug concentrations. Mar 08, 2006 read implications of genetic polymorphisms in drug transporters for pharmacotherapy, cancer letters on deepdyve, the largest online rental service for scholarly research with thousands of academic publications available at your fingertips. The purpose of this study was to investigate the relationship between genetic polymorphisms of mdr1 c3435t, g2677ta and c1236t and response to the treatment in newly diagnosed hypertensive patients being treated with losartan.
Association study of genetic polymorphisms in proteins involved in oseltamivir transport, metabolism, and interactions with adverse reactions in mexican. Cytochrome p450 and abcb1 genetic polymorphisms and. A total of 74 newly diagnosed hypertension patients were included in the study. In this context, we have undertaken the functional analyses of the polymorphisms identified in drug transporter genes. Distribution of genetic polymorphisms of genes encoding drug. It is now clear that a significant proportion of these adverse drug reactions, as well as therapeutic failures, are caused by genetic polymorphism, genetically based interindividual differences in drug absorption, disposition. In the present study, we studied the genetic polymorphism in drug transporters, using organic cationcarnitine transporter octn2 as a model transporter. The term relates to the multiple forms of a gene that can exist. Read implications of genetic polymorphisms in drug transporters for pharmacotherapy, cancer letters on deepdyve, the largest online rental service for scholarly research with thousands of academic publications available at your fingertips. Indian j med res serial online 2014 cited 2020 apr 8. Molecular mechanisms of genetic polymorphisms of drug metabolism. Rhodamine transport is a robust marker of the drugtransport capacity of abcb1. The drug substance is shown as a rectangle which can pack together in a crystal in different arrangements. Rhodamine transport is a robust marker of the drug transport capacity of abcb1.
In simple visual terms, the following scheme shows how to envisage polymorphism. The common observation that patients with type 2 diabetes mellitus t2dm show a great variability in the individual response to the same drug treatment suggests the importance of a personalized care approach, in which the most appropriate treatment is indicated. Functionality of the atp domains, as well as correct interaction of these with the drugbinding domains are necessary for drug transport. They can be classified into either efflux or uptake proteins, depending on the direction of transport. However, the reported effects of variants in certain drug transporter genes have been inconsistent and, in some cases, conflicting among studies. Pdf one of the major causes of interindividual variation of drug effects is genetic variation of drug metabolism. The goal of pharmacogenetics is to predict a patients genetic response to a specific drug as a means of delivering the best possible medical treatment. Genetic polymorphism of the methotrexate transporter abcg2, blood pressure and markers of arterial function in patients with rheumatoid arthritis. The c3435t polymorphism of mdr1 gene was correlated with expression levels and functions of pgp. The first drug metabolising polymorphism was described over 40. Genetic polymorphism in drug transport vineetha menon 2. May 31, 2011 an important factor responsible for this variability is genetic polymorphism in genes that are involved in pkpd processes, including drug transporters, phase i and ii metabolizing enzymes, and drug targets, and other genes that interfere with drug response.
523 957 4 430 1364 569 1386 417 563 228 234 1078 320 108 1438 361 550 782 1450 817 1485 727 1008 1375 1372 399 387 695 253 266 294 1330 556 768 57 1448 1483 1153